Tiotropium clinical trials
Also written Spiriva and Spiriva Respimat.
Counted the way a researcher would: Tiotropium with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses tiotropium is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the tiotropium studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 30 Jan 2004 · SPIRIVA · NDA 021395 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
147 studies that test it; most in 2002 (15)
| Year | Studies |
|---|---|
| 1998 | 2 |
| 1999 | 1 |
| 2000 | 4 |
| 2001 | 3 |
| 2002 | 15 |
| 2003 | 6 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 15 |
| 2007 | 8 |
| 2008 | 12 |
| 2009 | 4 |
| 2010 | 9 |
| 2011 | 9 |
| 2012 | 4 |
| 2013 | 7 |
| 2014 | 7 |
| 2015 | 2 |
| 2016 | 7 |
| 2017 | 11 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 99 · Other 48
Boehringer Ingelheim (71) · GlaxoSmithKline (5) · Novartis Pharmaceuticals (5) · Solventum US LLC (4) · University of Saskatchewan (4) · Orion Corporation, Orion Pharma (3) · University of Dundee (3) · James J. Peters Veterans Affairs Medical Center (2)
Often tested with
Tested in the same studies.
Salmeterol Xinafoate (17) · Olodaterol (12) · Formoterol (11) · Fluticasone (8) · Indacaterol (7) · Glycopyrrolate (5) · Budesonide (4) · BEA 2180 (3)
Related medicines
As reviewed, each with the page that says it.
- One of Bronchodilators source
- One of Cholinergic Antagonists source
- One of Antimuscarinics source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test tiotropium.
- Jan 2027Evaluating the Impact of Single Dose Tiotropium on Allergen-induced Early Asthmatic ResponsePhase 4 · University of Saskatchewan
Studies
Open first, then newest update. How each study uses tiotropium is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 147
- PREterm Infants With Bronchial Obstruction - Prospective Study of Efficacy and Safety of Inhaled TiotropiumNot yet recruitingPhase 4General University Hospital, PragueNCT07827859Written as tiotropium bromide (Spiriva Respimat)How we know
- Evaluating the Impact of Single Dose Tiotropium on Allergen-induced Early Asthmatic ResponseNot yet recruitingPhase 4University of SaskatchewanNCT06679465Written as Tiotropium (Spiriva®)How we know
- Effect of Tiotropium on Airway Remodeling in Patients With Early Stage COPD Accessed by Optical Coherence TomographyCompletedNot applicableGuangzhou Institute of Respiratory DiseaseNCT03842839Written as Tiotropium Inhalation Powder [Spiriva] 0.018mgHow we know
- Comparative Efficacy of Once-daily LAMA/LABA Combinations Versus Tiotropium on Constant-work-rate Cycle Endurance in COPDSuspendedNot applicableMedical University of BialystokNCT07541378Written as TiotropiumHow we know
- Tiotropium/Salmeterol Inhalation Powder in COPDTerminatedPhase 3Boehringer IngelheimNCT00668772Written as Tiotropium/SalmeterolHow we know
- Effects of Tiotropium/Olodaterol on Cardio-pulmonary Exercise Capacity in Patients With Hyperinflated Chronic Obstructive Pulmonary Disease [ACHIEVE]CompletedNot applicableYonsei UniversityNCT04994574Written as tiotropium/olodaterolHow we know
- Tiotropium vs. Inhaled Corticosteroids in Children With Nonatopic Asthma Pilot Study (TioNAAP)TerminatedPhase 2Nemours Children's ClinicNCT04990167Written as Tiotropium BromideHow we know
- Two-period 21 Day Cross-over Study to Compare the Pharmacokinetics of Tiotropium From Two InhalersCompletedPhase 1Kindeva Drug DeliveryNCT03246581Written as TiotropiumHow we know
- Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 2Boehringer IngelheimNCT02175342Written as Tiotropium 0.625 mcg/puffHow we know
- A Randomised, Double- Blind, Placebo Controlled, Cross-over Efficacy and Safety Comparison of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for Four Weeks in Patients With Moderate Persistent AsthmaCompletedPhase 2Boehringer IngelheimNCT01152450Written as Tiotropium 2.5 µg b.i.dHow we know
- Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With ReferenceCompletedPhase 1Solventum US LLCNCT03302065Written as TiotropiumHow we know
- Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With A Reference ProductCompletedEarly Phase 1Solventum US LLCNCT03155204Written as tiotropium pMDIHow we know
- Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With Two Reference ProductsCompletedPhase 1Solventum US LLCNCT02627625Written as TiotropiumHow we know
- Cross-over Study in Volunteers to Compare the Pharmacokinetics of Tiotropium Delivered From Test and Reference ProductsCompletedPhase 1Solventum US LLCNCT02676297Written as tiotropiumHow we know
- Anti-inflammatory Effects of Tiotropium in Patients with Stable COPDCompletedPhase 4University Medical Center GroningenNCT04061161Written as Tiotropium BromideHow we know
- Efficacy of Intermittent Tiotropium in Early Childhood WheezingTerminatedPhase 4Helsinki University Central HospitalNCT03199976Written as Tiotropium BromideHow we know
- Open Label Study to Assess the Effect of Patient Use and Robustness of Tiotropium 18ug Inhalation Powder, Hard Capsule,Zephir Inhaler DeviceCompletedPhase 1Xiromed LLCNCT06254664Written as Tiotropium 18 µg inhalation powder, hard capsuleHow we know
- 12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD)CompletedPhase 4Boehringer IngelheimNCT00144196Written as tiotropium (Spiriva)How we know
- Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients.CompletedPhase 4Boehringer IngelheimNCT00388882Written as tiotropiumHow we know
- A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.CompletedPhase 3Boehringer IngelheimNCT00274560Written as TiotropiumHow we know
See all 147 studies that test tiotropium →
Given beside what is tested · 38 — tiotropium is usual care or a partner of the new treatment
- Salvational Intervention for Reducing AECOPD Under Severe Air PollutionCompletedNot applicablePeking University First HospitalNCT03083067Written as tiotropium bromideHow we know
- Pharmacokinetic Study Comparing Tiotropium Easyhaler® and Spiriva® HandiHaler®CompletedPhase 1Orion Corporation, Orion PharmaNCT04850144Written as Tiotropium Bromide MonohydrateHow we know
- A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 4GlaxoSmithKlineNCT03478696Written as tiotropiumHow we know
- A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 4GlaxoSmithKlineNCT03478683Written as tiotropiumHow we know
- Bronchodilator Effect of RPL554 Administered in Addition to Tiotropium/Olodaterol in Patients With COPDCompletedPhase 2Verona Pharma plcNCT03673670Written as Tiotropium/olodaterol (Respimat)How we know
- Effect of Tiotropium + Olodaterol on Breathlessness in COPD PatientsCompletedPhase 4Boehringer IngelheimNCT02853123Written as TiotropiumHow we know
- Comparing the Efficacy of Tiotropium + Olodaterol Fixed Dose Combination (FDC) Over Tiotropium in Improvement of Lung Hyperinflation, Exercise Capacity and Physical Activity in Japanese COPD PatientsCompletedPhase 3Boehringer IngelheimNCT02629965Written as tiotropiumHow we know
- Beta Blocker Therapy in Moderate to Severe COPDCompletedPhase 4University of DundeeNCT01656005Written as TiotropiumHow we know
- The Effects of RPL554 in Addition to Tiotropium in COPD PatientsCompletedPhase 2Verona Pharma plcNCT03028142Written as 1.5 mg RPL554 plus tiotropiumHow we know
- Effect of Yong Chong Cao Capsule on Outcomes in Patients With Mild to Severe COPDStatus unknownPhase 3Henan University of Traditional Chinese MedicineNCT03745261Written as Tiotropium Bromide (Spiriva®)How we know
- Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.CompletedPhase 3Boehringer IngelheimNCT02296138Written as tiotropiumHow we know
- Safety Study Using GSK233705 And Tiotropium In Patients With Chronic Obstructive Pulmonary DiseaseCompletedPhase 1GlaxoSmithKlineNCT00279019Written as TiotropiumHow we know
- Effect of GSK1160724 In Healthy VolunteersCompletedPhase 1GlaxoSmithKlineNCT00555022Written as Tiotropium bromideHow we know
- Safety Study Using GSK573719 And Tiotropium In Patients With Chronic Obstructive Pulmonary DiseaseCompletedPhase 2GlaxoSmithKlineNCT00515502Written as TiotropiumHow we know
- Lung Function and Patient Preference With QVA149 vs. Tiotropium in COPD PatientsCompletedPhase 4Novartis PharmaceuticalsNCT02125734Written as TiotropiumHow we know
- Tiotropium Respimat Versus HandiHaler on SaO2 and Sleep in COPD PatientsCompletedNot applicableUniversity of CreteNCT02331940Written as tiotropiumHow we know
- To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of AirwaysCompletedPhase 3Boehringer IngelheimNCT02085161Written as tiotropium+olodaterolHow we know
- A Study to Determine the Effect of Tiotropium + Olodaterol Fixed Dose Combination on Exercise Endurance Time During Constant Work Rate Cycle Ergometry Test in COPDCompletedPhase 3Boehringer IngelheimNCT01525615Written as tiotropium+olodaterol (low dose)How we know
- Pharmacokinetics and Safety of BI 1744 CL Plus Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 1Boehringer IngelheimNCT02231177Written as BI 1744 CL/Tiotropium FDCHow we know
- Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.CompletedPhase 3Boehringer IngelheimNCT01533935Written as Tiotropium + OlodaterolHow we know
Showing 20 of 38.
As the comparator · 79 — what is tested is compared with tiotropium
- Tiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol Polyethylene (PE) Capsule) in Chronic Obstructive Pulmonary Disease (COPD)TerminatedPhase 3Boehringer IngelheimNCT00662740Written as Tiotropium (Spiriva®)How we know
- ANTES B+ Clinical TrialTerminatedPhase 4Fundacio Privada Mon Clinic BarcelonaNCT06282861Written as SpirivaHow we know
- Efficacy and Safety of Indacaterol vs Tiotropium in Women With COPD Secondary to Biomass ExposureCompletedPhase 4National Institute of Respiratory Diseases, MexicoNCT05506865Written as TiotropiumHow we know
- Phase 4 COPD and Suboptimal Inspiratory Flow RateCompletedPhase 4Theravance BiopharmaNCT05165485Written as TiotropiumHow we know
- A Trial to Assess the Bioequivalence of Generic Tiotropium Bromide Inhalation Powder and Reference Product in Healthy Adult Participants Under Fasting Conditions (Pilot)Active, not recruitingPhase 1Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06326671Written as Spiriva HandiHalerHow we know
- Bioequivalence Study of Tiotropium 18 μg Inhalation Powder, Hard Capsule With Spiriva®Handihaler® 18 μg Inhalation Powder, Hard Capsule in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 3Xiromed LLCNCT05986591Written as Spiriva Handihaler (Tiotropium Bromide) 18 mcgHow we know
- Bioequivalence Study of Tiotropium Bromide Inhalation PowderCompletedPhase 3Phargentis SANCT05161156Written as 18 mcg of Spiriva (Reference Product)How we know
- A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 3Mylan Inc.NCT02518139Written as TiotropiumHow we know
- Revefenacin Peak Inspiratory Flow Rate (PIFR) Study in COPDCompletedPhase 3Mylan Inc.NCT03095456Written as Spiriva Handihaler®How we know
- A Study of 3 Doses of Tiotropium Hydrofluoralkane (HFA) Breath Actuated Inhaler (BAI), in Patients With Chronic Obstructive Pulmonary DiseaseWithdrawnPhase 2Teva Branded Pharmaceutical Products R&D, Inc.NCT02203474Written as Tiotropium 18 mcg CapsuleHow we know
- Safety and Efficacy Study of Glyco pMDI After Single and Repeated AdministrationCompletedPhase 1/2Chiesi Farmaceutici S.p.A.NCT01176903Written as TiotropiumHow we know
- Non Inferiority of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) Versus Combination of Fluticasone Furoate (FlF)/Vilanterol (VI) + Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 3Chiesi Farmaceutici S.p.A.NCT02467452Written as FlF/VI + TiotropiumHow we know
- Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate in Chronic Obstructive Pulmonary DiseaseCompletedPhase 3Chiesi Farmaceutici S.p.A.NCT01911364Written as TiotropiumHow we know
- Study to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + TiotropiumCompletedPhase 3Novartis PharmaceuticalsNCT03158311Written as Salmeterol/fluticasone plus tiotropiumHow we know
- PET Study to Determine Muscarinic Receptor Occupancy in Lungs After Inhalation of AZD2115 and TiotropiumCompletedPhase 1AstraZenecaNCT03097380Written as SPIRIVAHow we know
- A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedPhase 2Chiesi Farmaceutici S.p.A.NCT03084796Written as Tiotropium Bromide 18 µg Inhalation CapsuleHow we know
- Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device RobustnessCompletedPhase 3Lupin, Inc.NCT03137992Written as Reference Product (Spiriva®)How we know
- Safety and Tolerability QAT370 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary DiseaseCompletedPhase 1NovartisNCT00532350Written as TiotropiumHow we know
- Safety and Efficacy of Multiple Doses of QAX028 in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedPhase 2Novartis PharmaceuticalsNCT01068613Written as TiotropiumHow we know
- Efficacy and Safety of PT001 to Placebo and Open-label Spiriva® Respimat® in Subjects With Persistant AsthmaCompletedPhase 2/3Pearl Therapeutics, Inc.NCT03358147Written as Spiriva Respimat 2.5 μgHow we know
Showing 20 of 79.
Codes
What other systems call tiotropium · ClinicalTrials.gg INT006581
- MeSH (NLM) D000069447Tiotropium BromideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 0EB439235FTIOTROPIUMConfirmed FDA, NLM, Wikidata
- RxNorm 69120Confirmed FDA, Wikidata
- Wikidata Q424316tiotropiumConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C76004TiotropiumOne source FDA
- DrugBank DB01409One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069447 | Tiotropium Bromide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 0EB439235F | TIOTROPIUM | Confirmed FDA, NLM, Wikidata |
| RxNorm | 69120 | — | Confirmed FDA, Wikidata |
| Wikidata | Q424316 | tiotropium | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C76004 | Tiotropium | One source FDA |
| DrugBank | DB01409 | — | One source Wikidata |
Also registered as tiotropium bromide anhydrous (UNII XX112XZP0J · RxNorm 393575) and tiotropium bromide monohydrate (UNII L64SXO195N · RxNorm 1298831).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.